Blue Owl Capital Corporation
VC Fund
New York, United States
Blue Owl Capital Corporation is a VC fund in New York focused on SaaS and Software. Owl Rock aims to meet the distinct and underserved financing needs of middle-market companies through tailored “one-stop” financing solutions across the capital structure. Its seasoned executives’ experience in designing and funding custom solutions positions us as a desirable lending partner to middle-market companies and their sponsors.Itdeploys capital through Owl Rock Capital Corporation, which has elected to be treated as a business development company under the Investment Company Act of 1940, as amended. Owl Rock Capital Corporation will originate, underwrite and invest in senior secured or unsecured loans, subordinated loans or mezzanine loans and, to a lesser extent, equity-related securities and warrants. Owl Rock Capital Advisors, a SEC-registered investment adviser, manages Owl Rock Capital Corporation.
- Total investments:
- 54
- Last investment:
- Lead investor:
- 41%
- Fund size:
- $1.1B
- Last fund:
Last updated:
For AI agents: llms.txt
Industries Blue Owl Capital Corporation invests in
Stages Blue Owl Capital Corporation invests in
Countries Blue Owl Capital Corporation invests in
Round sizes
Contacts
| Name | Phone | Socials | |
|---|---|---|---|
Round size
- Series E
- $100M–$385M
- Series F
- $85M–$300M
- Debt Financing
- $200M–$3.5B
Investment Focus
Industry
- SaaS 10 (19%)
- Software 9 (17%)
- FinTech 8 (15%)
- Financial Services 8 (15%)
- Finance 7 (13%)
Stage
- Series E 8 (15%)
- Series F 8 (15%)
- Debt Financing 8 (15%)
- Series C 6 (11%)
- Series D 5 (9%)
Country
- United States 33 (61%)
- Brazil 1 (2%)
- Estonia 1 (2%)
- Colombia 1 (2%)
- Australia 1 (2%)
Team
| Name | Title | Investments | Links | |
|---|---|---|---|---|
|
Douglas I. Ostrover
Co-Founder and Chief Executive Officer
|
Co-Founder and Chief Executive Officer | Total investments: 0 | Find email | |
Douglas I. Ostrover
Co-Founder and Chief Executive Officer
|
Co-Founder and Chief Executive Officer | Total investments: 1 | Find email | |
Erik Bissonnette
Managing Director
|
Managing Director | Total investments: 0 | Find email | |
Marc Lipschultz
Co-Founder, President & Co-Chief Investment Officer
|
Co-Founder, President & Co-Chief Investment Officer | Total investments: 0 | Find email | |
Pravin Vazirani
Managing Director
|
Managing Director | Total investments: 34 | Find email |
Investments
| Company | Description | Round | Links |
|---|---|---|---|
CAIS
|
CAIS is a financial technology platform, providing independent financial advisors with access to top-tier managers of specialized investment products in the multi-trillion-dollar independent wealth channel.The company offers streamlined execution for an expanding list of alternative investment funds and products. Financial advisors use theplatform to access funds and products, including hedge funds, private equity, private credit, real estate, structured notes, and digital assets. CAIS complements its fund offerings with independent due diligence provided by Mercer. CAIS is an NFA member with securities offered through CAIS Capital LLC, member FINRA, SIPC.Jeremy Norton and Matt Brown co-founded CAIS in New York, New York in 2009. | $170M / Series D / Jul 29, 2026 | |
Cleveland Cavaliers
|
Cleveland Cavaliers, also known as the Cavs, are an American professional basketball team based in Cleveland, Ohio. | Private Equity / Jul 06, 2026 | |
Perk.com
|
Perk is the #1 Mobile Rewards program with millions of members worldwide. Perk believes that advertising today is a one-way street and pits advertisers against users and publishers. Perk is aiming to make the world more rewarding by creating a better relationship between advertisers, consumers, and publishers. | $300M / Debt Financing / Jun 03, 2026 | |
TG Therapeutics
|
TG Therapeutics is an innovative, clinical-stage biopharmaceutical company focused on the acquisition, development and commercialization of medically important pharmaceutical products for the treatment of cancer and other underserved therapeutic needs. Currently, the company is developing two therapies targeting hematological malignancies. TG-1101(ublituximab) is a novel, glycoengineered, third generation monoclonal antibody that targets a specific and unique epitope on the CD20 antigen found on mature B-lymphocytes. TG Therapeutics is also developing TGR-1202, an orally available PI3K delta inhibitor. The delta isoform of PI3K is strongly expressed in cells of hematopoietic origin and is believed to be important in the proliferation and survival of B-lymphocytes. Both TG-1101 and TGR-1202 are in clinical development for patients with hematologic malignancies. TG Therapeutics is headquartered in New York City and is traded on NASDAQ under the ticker symbol "TGTX". | $750M / Post-IPO Debt / Mar 19, 2026 | |
Vestwell
|
Vestwell provides the underlying infrastructure to power workplace savings and investing programs, such as 401(k) & 403(b) retirement plans. Their cloud-based digital recordkeeping platform provides the modern architecture to support financial services and payroll partners while bringing clients an easier, more flexible, and user-friendlyexperience delivered at a fraction of the cost. | $385M / Series E / Feb 18, 2026 | |
Clearwater Analytics
|
Clearwater Analytics® provides a software-as-a-service (SaaS) solution for automated investment data aggregation, reconciliation, accounting, and reporting, and analytics for institutional investors, investment managers, custody banks, and electronic trading portals. Launched in 2004, with offices in Boise, Idaho, NYC, Seattle, London, Edinburgh,New Delhi, and Singapore, Clearwater Analytics reports on more than $5.6 trillion in assets for clients that include leading insurers, asset managers, corporations, pension plans, governments, and non-profit organizations. | $3.5B / Debt Financing / Feb 13, 2026 | |
RobinFood
|
RobinFood is the leader in cloud-restaurants in Latin America with presence in Colombia, Brazil and Mexico. RobinFood was founded in 2018 | $4M / Venture - Series Unknown / May 21, 2024 | |
Trucordia
|
PCF is a full-service insurance brokerage firm which provides complete risk management solutions with a broad array of property & casualty, life and health, employee benefits and workers' compensation insurance products. | $500M / Private Equity / Feb 17, 2023 | |
Juniper Square
|
Founded in 2014, Juniper Square is transforming private equity with innovative software and solutions that deliver a more modern, efficient and effective approach to managing private partnerships. Designed to provide real-time information and workflow for all parties involved in a private partnership, Juniper Square enables forward-thinking GPs tolower administrative costs, increase investor satisfaction and raise more capital. Trusted by more than 1,200 GPs to manage more than 200,000 investors and $1.5 trillion in assets, Juniper Square has quickly become a leading provider of investment management and administration solutions for commercial real estate. The company was recognized as an Inc. 5000 2021 Fastest-Growing Company in America, a Deloitte Technology Fast 500 Company, and was named one of Forbes’ Best Startup Employers. Learn more at www.junipersquare.com. | $133M / Venture - Series Unknown / Feb 13, 2023 | |
|
Juniper Square
|
Founded in 2014, Juniper Square is transforming private equity with innovative software and solutions that deliver a more modern, efficient and effective approach to managing private partnerships. Designed to provide real-time information and workflow for all parties involved in a private partnership, Juniper Square enables forward-thinking GPs tolower administrative costs, increase investor satisfaction and raise more capital. Trusted by more than 1,200 GPs to manage more than 200,000 investors and $1.5 trillion in assets, Juniper Square has quickly become a leading provider of investment management and administration solutions for commercial real estate. The company was recognized as an Inc. 5000 2021 Fastest-Growing Company in America, a Deloitte Technology Fast 500 Company, and was named one of Forbes’ Best Startup Employers. Learn more at www.junipersquare.com. | $133M / Private Equity / Feb 13, 2023 | |
| See all 54 investments → | |||
Co-Investors
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Similar industry
Featured in Investor Lists
Recommended lists
FAQ
What does Blue Owl Capital Corporation invest in?
Blue Owl Capital Corporation invests primarily in SaaS, Software and FinTech startups, most often at Series E and Series F stage. Most of the 54 investments tracked by Shizune back companies in United States. The Investment Focus section breaks down every industry, stage and country in the portfolio.
What is Blue Owl Capital Corporation's check size?
Blue Owl Capital Corporation typically joins rounds of $100M–$385M at Series E, $85M–$300M at Series F and $200M–$3.5B at Debt Financing. These ranges are 10th–90th percentile round sizes calculated from confirmed public funding rounds, so they are a realistic guide to the rounds Blue Owl Capital Corporation participates in.
How do I contact Blue Owl Capital Corporation?
Public channels for Blue Owl Capital Corporation include LinkedIn, X (Twitter) and the website linked on this profile. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.
Who are the partners at Blue Owl Capital Corporation?
The team at Blue Owl Capital Corporation includes Douglas I. Ostrover (Co-Founder and Chief Executive Officer), Douglas I. Ostrover (Co-Founder and Chief Executive Officer) and Erik Bissonnette (Managing Director). The Team section lists each member with their title, investment count and links.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
